B&G Foods Reports Financial Results for Third Quarter 2022
B&G Foods reported a 2.6% increase in net sales for Q3 2022, totaling $528.4 million, driven by higher net pricing and an improved product mix. However, the company faced a net loss of $59.6 million or $0.83 per diluted share, significantly down from net income of $20.7 million in Q3 2021. Adjusted EBITDA fell 16.6% to $80.2 million. Despite these challenges, B&G reaffirmed its full-year net sales guidance at $2.10 billion to $2.14 billion, but revised adjusted EBITDA guidance to $290 million to $300 million due to ongoing inflation and supply chain issues.
- Net sales increased 2.6% to $528.4 million for Q3 2022.
- Full-year net sales guidance reaffirmed at $2.10 billion to $2.14 billion.
- Net loss of $59.6 million, significantly worse than Q3 2021.
- Adjusted EBITDA decreased by 16.6%, from $96.2 million in Q3 2021.
- Inflationary pressures continue to significantly impact gross profit.
— Net Sales Increased
Summary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third Quarter of 2022 |
|
First Three Quarters of 2022 |
||||||||
(In millions, except per share data) |
|
|
Change vs. |
|
|
|
Change vs. |
|||||
|
|
Amount |
|
Q3 2021 |
|
Amount |
|
First 3Q 2021 |
||||
|
|
$ |
528.4 |
|
2.6 |
% |
|
$ |
1,539.8 |
|
3.7 |
% |
Base Business |
|
$ |
527.5 |
|
2.5 |
% |
|
$ |
1,538.0 |
|
3.8 |
% |
Diluted EPS 1 |
|
$ |
(0.83) |
|
(359.4) |
% |
|
$ |
(0.51) |
|
(146.4) |
% |
Adj. Diluted EPS 1 |
|
$ |
0.31 |
|
(43.6) |
% |
|
$ |
0.67 |
|
(55.0) |
% |
Net Loss 1 |
|
$ |
(59.6) |
|
(387.2) |
% |
|
$ |
(35.7) |
|
(149.4) |
% |
Adj. Net Income 1 |
|
$ |
22.3 |
|
(38.5) |
% |
|
$ |
47.3 |
|
(51.4) |
% |
Adj. EBITDA 1 |
|
$ |
80.2 |
|
(16.6) |
% |
|
$ |
207.3 |
|
(24.0) |
% |
Guidance for Full Year Fiscal 2022
-
Net sales reaffirmed at a range of
to$2.10 billion .$2.14 billion -
Adjusted EBITDA revised to a range of
to$290 million .$300 million -
Adjusted diluted earnings per share revised to a range of
to$0.90 .$1.00
Commenting on the results,
Financial Results for the Third Quarter of 2022
Net sales for the third quarter of 2022 increased
Base business net sales for the third quarter of 2022 increased
Net sales of Crisco increased
Gross profit was
During the third quarter of 2022, the Company’s gross profit was negatively impacted by input cost inflation, including materially increased costs for raw materials and transportation. The Company expects input cost inflation will continue to have a significant industry-wide impact during the remainder of fiscal 2022 and into fiscal 2023. The Company is attempting to mitigate the impact of inflation on its gross profit by locking in prices through short-term supply contracts and advance commodities purchase agreements and by implementing cost saving measures. The Company also announced list price increases in 2021 and again during the first, second, third and fourth quarters of 2022. However, increases in the prices the Company charges its customers generally lag behind rising input costs. As such, the Company did not fully offset the incremental costs that it faced in the third quarter of 2022 and may not fully offset the incremental costs that the Company is facing and expects to continue to face in the remainder of fiscal 2022 and beyond.
Selling, general and administrative expenses increased
During the third quarter of 2022, the Company recorded pre-tax, non-cash charges of
Net interest expense increased
The Company’s net loss was
For the third quarter of 2022, adjusted EBITDA was
Financial Results for the First Three Quarters of 2022
Net sales for the first three quarters of 2022 increased
Base business net sales for the first three quarters of 2022 increased
Net sales of Crisco increased
Gross profit was
During the first three quarters of 2022, the Company’s gross profit was negatively impacted by higher than expected input cost inflation, including materially increased costs for raw materials and transportation. The Company expects input cost inflation will continue to have a significant industry-wide impact during the remainder of fiscal 2022 and into fiscal 2023. The Company is attempting to mitigate the impact of inflation on its gross profit by locking in prices through short-term supply contracts and advance commodities purchase agreements and by implementing cost saving measures. The Company also announced list price increases in 2021 and again during the first, second, third and fourth quarters of 2022. However, increases in the prices the Company charges its customers generally lag behind rising input costs. As such, the Company did not fully offset the incremental costs that it faced in the first three quarters of 2022 and may not fully offset the incremental costs that the Company is facing and expects to continue to face in the remainder of fiscal 2022 and beyond.
Selling, general and administrative expenses decreased
During the first quarter of 2022, the Company completed the closure and sale of its
During the third quarter of 2022, the Company recorded pre-tax, non-cash charges of
Net interest expense increased
The Company’s net loss was
For the first three quarters of 2022, adjusted EBITDA was
Impairment of Assets Held for Sale
In connection with the Company’s previously announced transition to a business unit structure, the Company has decided to divest its Back to Nature business, which is no longer core to the Company’s overall business or long-term strategy. The Company is actively seeking to sell the Back to Nature business. As a result, the Company reclassified
Dividends
Including the dividend payment that the Company made in the fourth quarter on
Full Year Fiscal 2022 Guidance
Conference Call
About Non-GAAP Financial Measures and Items Affecting Comparability
“Adjusted net income” (net income (loss) adjusted for certain items that affect comparability), “adjusted diluted earnings per share,” (diluted earnings (loss) per share adjusted for certain items that affect comparability), “base business net sales” (net sales without the impact of acquisitions until the acquisitions are included in both comparable periods and without the impact of discontinued or divested brands), “EBITDA” (net income (loss) before net interest expense, income taxes and depreciation and amortization) and “adjusted EBITDA” (EBITDA as adjusted for cash and non-cash acquisition/divestiture-related expenses, gains and losses (which may include third party fees and expenses, integration, restructuring and consolidation expenses, amortization of acquired inventory fair value step-up and gains and losses on the sale of certain assets), loss on extinguishment of debt, impairment of assets held for sale, and non-recurring expenses, gains and losses) are “non-GAAP financial measures.” A non-GAAP financial measure is a numerical measure of financial performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with generally accepted accounting principles in
The Company uses non-GAAP financial measures to adjust for certain items that affect comparability. This information is provided in order to allow investors to make meaningful comparisons of the Company’s operating performance between periods and to view the Company’s business from the same perspective as the Company’s management. Because the Company cannot predict the timing and amount of these items that affect comparability, management does not consider these items when evaluating the Company’s performance or when making decisions regarding allocation of resources.
Additional information regarding EBITDA and adjusted EBITDA and a reconciliation of EBITDA and adjusted EBITDA to net income (loss) and to net cash provided by operating activities, is included below for the third quarter and first three quarters of 2022 and 2021, along with the components of EBITDA and adjusted EBITDA. Also included below are reconciliations of the non-GAAP terms adjusted net income, adjusted diluted earnings per share and base business net sales to the most directly comparable measure calculated and presented in accordance with GAAP in the Company’s consolidated balance sheets and related consolidated statements of operations, comprehensive income, changes in stockholders’ equity and cash flows.
End Notes
- Please see “About Non-GAAP Financial Measures and Items Affecting Comparability” below for the definition of the non-GAAP financial measures “base business net sales,” “adjusted diluted earnings per share,” “adjusted net income,” “EBITDA” and “adjusted EBITDA,” as well as information concerning certain items affecting comparability and reconciliations of the non-GAAP terms to the most comparable GAAP financial measures.
- Includes the spices & seasoning brands acquired in the fourth quarter of 2016, as well as the Company’s legacy spices & seasonings brands, such as Dash and Ac’cent, and spices & seasonings products launched by the Company and sold under license.
About
Based in
Forward-Looking Statements
Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements.” The forward-looking statements contained in this press release include, without limitation, statements related to B&G Foods’ expectations regarding net sales, adjusted EBITDA, adjusted diluted earnings per share, consumer demand, input cost inflation, list price increases, cost savings initiatives, the ability of the Company to recover higher costs in the fourth quarter of 2022 and beyond through pricing actions, the Company’s overall expectations for the remainder of fiscal 2022 and beyond, the potential sale of the Back to Nature business, and the Company’s current intended dividend rate. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the actual results of
Consolidated Balance Sheets (In thousands, except share and per share data) (Unaudited) |
|||||
|
|
|
|
|
|
|
|
|
|
||
|
2022 |
|
2022 |
||
Assets |
|
|
|
|
|
Current assets: |
|
|
|
|
|
Cash and cash equivalents |
$ |
60,064 |
|
$ |
33,690 |
Trade accounts receivable, net |
|
175,702 |
|
|
145,281 |
Inventories |
|
805,188 |
|
|
609,794 |
Assets held for sale |
|
54,245 |
|
|
3,256 |
Prepaid expenses and other current assets |
|
42,401 |
|
|
38,151 |
Income tax receivable |
|
11,817 |
|
|
4,284 |
Total current assets |
|
1,149,417 |
|
|
834,456 |
|
|
|
|
|
|
Property, plant and equipment, net |
|
325,890 |
|
|
341,471 |
Operating lease right-of-use assets |
|
69,565 |
|
|
65,166 |
Finance lease right-of-use assets |
|
3,155 |
|
|
— |
|
|
619,095 |
|
|
644,871 |
Other intangible assets, net |
|
1,793,034 |
|
|
1,927,119 |
Other assets |
|
14,004 |
|
|
6,916 |
Deferred income taxes |
|
9,414 |
|
|
8,546 |
Total assets |
$ |
3,983,574 |
|
$ |
3,828,545 |
|
|
|
|
|
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
Trade accounts payable |
$ |
228,248 |
|
$ |
129,861 |
Accrued expenses |
|
72,677 |
|
|
66,901 |
Current portion of operating lease liabilities |
|
15,038 |
|
|
12,420 |
Current portion of finance lease liabilities |
|
1,040 |
|
|
— |
Income tax payable |
|
3 |
|
|
2,557 |
Dividends payable |
|
34,043 |
|
|
32,548 |
Total current liabilities |
|
351,049 |
|
|
244,287 |
|
|
|
|
|
|
Long-term debt |
|
2,418,090 |
|
|
2,267,759 |
Deferred income taxes |
|
284,038 |
|
|
310,641 |
Long-term operating lease liabilities, net of current portion |
|
55,032 |
|
|
55,607 |
Long-term finance lease liabilities, net of current portion |
|
2,058 |
|
|
— |
Other liabilities |
|
31,733 |
|
|
29,997 |
Total liabilities |
|
3,142,000 |
|
|
2,908,291 |
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
Preferred stock, |
|
— |
|
|
— |
Common stock, |
|
717 |
|
|
685 |
Additional paid-in capital |
|
— |
|
|
3,547 |
Accumulated other comprehensive loss |
|
(24,642) |
|
|
(18,169) |
Retained earnings |
|
865,499 |
|
|
934,191 |
Total stockholders’ equity |
|
841,574 |
|
|
920,254 |
Total liabilities and stockholders’ equity |
$ |
3,983,574 |
|
$ |
3,828,545 |
Consolidated Statements of Operations (In thousands, except per share data) (Unaudited) |
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Third Quarter Ended |
|
First Three Quarters Ended |
||||||||
|
|
|
|
|
|
|
|
||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Net sales |
$ |
528,396 |
|
$ |
514,965 |
|
$ |
1,539,768 |
|
$ |
1,484,474 |
Cost of goods sold |
|
422,635 |
|
|
409,300 |
|
|
1,256,222 |
|
|
1,149,425 |
Gross profit |
|
105,761 |
|
|
105,665 |
|
|
283,546 |
|
|
335,049 |
|
|
|
|
|
|
|
|
|
|
|
|
Operating (income) and expenses: |
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
47,519 |
|
|
46,409 |
|
|
138,556 |
|
|
143,864 |
Amortization expense |
|
5,427 |
|
|
5,396 |
|
|
16,009 |
|
|
16,231 |
Gain on sales of assets |
|
— |
|
|
— |
|
|
(7,099) |
|
|
— |
Impairment of assets held for sale |
|
103,625 |
|
|
— |
|
|
103,625 |
|
|
— |
Operating income (loss) |
|
(50,810) |
|
|
53,860 |
|
|
32,455 |
|
|
174,954 |
|
|
|
|
|
|
|
|
|
|
|
|
Other (income) and expenses: |
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net |
|
31,874 |
|
|
26,630 |
|
|
88,617 |
|
|
80,312 |
Other income |
|
(1,846) |
|
|
(1,130) |
|
|
(5,533) |
|
|
(3,338) |
Income (loss) before income tax expense (benefit) |
|
(80,838) |
|
|
28,360 |
|
|
(50,629) |
|
|
97,980 |
Income tax expense (benefit) |
|
(21,255) |
|
|
7,613 |
|
|
(14,958) |
|
|
25,804 |
Net income (loss) |
$ |
(59,583) |
|
$ |
20,747 |
|
$ |
(35,671) |
|
$ |
72,176 |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
71,670 |
|
|
64,845 |
|
|
70,068 |
|
|
64,735 |
Diluted |
|
72,018 |
|
|
65,493 |
|
|
70,440 |
|
|
65,371 |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
(0.83) |
|
$ |
0.32 |
|
$ |
(0.51) |
|
$ |
1.11 |
Diluted |
$ |
(0.83) |
|
$ |
0.32 |
|
$ |
(0.51) |
|
$ |
1.10 |
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends declared per share |
$ |
0.475 |
|
$ |
0.475 |
|
$ |
1.425 |
|
$ |
1.425 |
Items Affecting Comparability Reconciliation of Net Income (Loss) to EBITDA and Adjusted EBITDA (In thousands) (Unaudited) |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third Quarter Ended |
|
First Three Quarters Ended |
||||||||
|
|
|
|
|
|
|
|
|
||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Net income (loss) |
|
$ |
(59,583) |
|
$ |
20,747 |
|
$ |
(35,671) |
|
$ |
72,176 |
Income tax expense (benefit) |
|
|
(21,255) |
|
|
7,613 |
|
|
(14,958) |
|
|
25,804 |
Interest expense, net |
|
|
31,874 |
|
|
26,630 |
|
|
88,617 |
|
|
80,312 |
Depreciation and amortization |
|
|
20,766 |
|
|
20,728 |
|
|
61,065 |
|
|
61,257 |
EBITDA(1) |
|
|
(28,198) |
|
|
75,718 |
|
|
99,053 |
|
|
239,549 |
Acquisition/divestiture-related and non-recurring expenses(2) |
|
|
4,785 |
|
|
6,388 |
|
|
9,575 |
|
|
14,217 |
Gain on sale of assets, net of facility closure costs(3) |
|
|
— |
|
|
— |
|
|
(4,928) |
|
|
— |
Amortization of acquisition-related inventory step-up(4) |
|
|
— |
|
|
— |
|
|
— |
|
|
5,054 |
Accrual for multi-employer pension plan withdrawal liability(5) |
|
|
— |
|
|
14,056 |
|
|
— |
|
|
14,056 |
Impairment of assets held for sale(6) |
|
|
103,625 |
|
|
— |
|
|
103,625 |
|
|
— |
Adjusted EBITDA(1) |
|
$ |
80,212 |
|
$ |
96,162 |
|
$ |
207,325 |
|
$ |
272,876 |
Items Affecting Comparability Reconciliation of Net Cash Provided by (Used in) Operating Activities to EBITDA and Adjusted EBITDA (In thousands) (Unaudited) |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third Quarter Ended |
|
First Three Quarters Ended |
||||||||
|
|
|
|
|
|
|
|
|
||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Net cash provided by (used in) operating activities |
|
$ |
(69,535) |
|
$ |
(53,179) |
|
$ |
(48,408) |
|
$ |
12,786 |
Income tax expense (benefit) |
|
|
(21,255) |
|
|
7,613 |
|
|
(14,958) |
|
|
25,804 |
Interest expense, net |
|
|
31,874 |
|
|
26,630 |
|
|
88,617 |
|
|
80,312 |
Gain on sales of assets |
|
|
(19) |
|
|
(30) |
|
|
7,094 |
|
|
— |
Deferred income taxes |
|
|
27,945 |
|
|
(3,524) |
|
|
27,415 |
|
|
(14,894) |
Amortization of deferred debt financing costs and bond discount/premium |
|
|
(1,184) |
|
|
(1,155) |
|
|
(3,530) |
|
|
(3,444) |
Share-based compensation expense |
|
|
(736) |
|
|
(1,103) |
|
|
(2,984) |
|
|
(3,228) |
Changes in assets and liabilities, net of effects of business combinations |
|
|
108,337 |
|
|
100,466 |
|
|
149,432 |
|
|
142,213 |
Impairment of assets held for sale(6) |
|
|
(103,625) |
|
|
— |
|
|
(103,625) |
|
|
— |
EBITDA(1) |
|
|
(28,198) |
|
|
75,718 |
|
|
99,053 |
|
|
239,549 |
Acquisition/divestiture-related and non-recurring expenses(2) |
|
|
4,785 |
|
|
6,388 |
|
|
9,575 |
|
|
14,217 |
Gain on sale of assets, net of facility closure costs(3) |
|
|
— |
|
|
— |
|
|
(4,928) |
|
|
— |
Amortization of acquisition-related inventory step-up(4) |
|
|
— |
|
|
— |
|
|
— |
|
|
5,054 |
Accrual for multi-employer pension plan withdrawal liability(5) |
|
|
— |
|
|
14,056 |
|
|
— |
|
|
14,056 |
Impairment of assets held for sale(6) |
|
|
103,625 |
|
|
— |
|
|
103,625 |
|
|
— |
Adjusted EBITDA(1) |
|
$ |
80,212 |
|
$ |
96,162 |
|
$ |
207,325 |
|
$ |
272,876 |
_________________________ | ||
(1) |
|
EBITDA and adjusted EBITDA are non-GAAP financial measures used by management to measure operating performance. A non-GAAP financial measure is defined as a numerical measure of the Company’s financial performance that excludes or includes amounts so as to be different from the most directly comparable measure calculated and presented in accordance with GAAP in the Company’s consolidated balance sheets and related consolidated statements of operations, comprehensive income, changes in stockholders’ equity and cash flows. The Company defines EBITDA as net income (loss) before net interest expense, income taxes and depreciation and amortization. The Company defines adjusted EBITDA as EBITDA adjusted for cash and non-cash acquisition/divestiture-related expenses, gains and losses (which may include third party fees and expenses, integration, restructuring and consolidation expenses, amortization of acquired inventory fair value step-up, and gains and losses on the sale of certain assets); loss on extinguishment of debt; impairment of assets held for sale; and non-recurring expenses, gains and losses. |
|
|
|
|
|
Management believes that it is useful to eliminate these items because it allows management to focus on what it deems to be a more reliable indicator of ongoing operating performance and the Company’s ability to generate cash flow from operations. The Company uses EBITDA and adjusted EBITDA in the Company’s business operations to, among other things, evaluate the Company’s operating performance, develop budgets and measure the Company’s performance against those budgets, determine employee bonuses and evaluate the Company’s cash flows in terms of cash needs. The Company also presents EBITDA and adjusted EBITDA because the Company believes they are useful indicators of the Company’s historical debt capacity and ability to service debt and because covenants in the Company’s credit agreement and the Company’s senior notes indentures contain ratios based on these measures. As a result, reports used by internal management during monthly operating reviews feature the EBITDA and adjusted EBITDA metrics. However, management uses these metrics in conjunction with traditional GAAP operating performance and liquidity measures as part of its overall assessment of company performance and liquidity, and therefore does not place undue reliance on these measures as its only measures of operating performance and liquidity. |
|
|
|
|
|
EBITDA and adjusted EBITDA are not recognized terms under GAAP and do not purport to be alternatives to operating income (loss), net income (loss) or any other GAAP measure as an indicator of operating performance. EBITDA and adjusted EBITDA are not complete net cash flow measures because EBITDA and adjusted EBITDA are measures of liquidity that do not include reductions for cash payments for an entity’s obligation to service its debt, fund its working capital, capital expenditures and acquisitions and pay its income taxes and dividends. Rather, EBITDA and adjusted EBITDA are potential indicators of an entity’s ability to fund these cash requirements. EBITDA and adjusted EBITDA are not complete measures of an entity’s profitability because they do not include certain costs and expenses and gains and losses described above. Because not all companies use identical calculations, this presentation of EBITDA and adjusted EBITDA may not be comparable to other similarly titled measures of other companies. However, EBITDA and adjusted EBITDA can still be useful in evaluating the Company’s performance against the Company’s peer companies because management believes these measures provide users with valuable insight into key components of GAAP amounts. |
|
|
|
(2) |
|
Acquisition/divestiture-related and non-recurring expenses for the third quarter and first three quarters of 2022 of |
|
|
|
(3) |
|
During the first quarter of 2022, the Company completed the closure and sale of its |
|
|
|
(4) |
|
For the first three quarters of 2021, amortization of acquisition-related inventory step-up of |
|
|
|
(5) |
|
During the third quarter of 2021, the Company reached an agreement to sell its |
|
|
|
(6) |
|
In connection with the Company’s previously announced transition to a business unit structure, the Company has decided to divest its Back to Nature business, which is no longer core to the Company’s overall business or long-term strategy. The Company is actively seeking to sell the Back to Nature business. As a result, the Company reclassified |
Items Affecting Comparability Reconciliation of Adjusted Net Income and Adjusted Diluted Earnings per Share to Net Income (Loss) (In thousands, except per share data) (Unaudited) |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thirteen Weeks Ended |
|
Thirty-nine Weeks Ended |
||||||||
|
|
|
|
|
|
|
|
|
||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Net income (loss) |
|
$ |
(59,583) |
|
$ |
20,747 |
|
$ |
(35,671) |
|
$ |
72,176 |
Acquisition/divestiture-related and non-recurring expenses(1) |
|
|
4,785 |
|
|
6,388 |
|
|
9,575 |
|
|
14,217 |
Gain on sale of assets, net of facility closure costs(2) |
|
|
— |
|
|
— |
|
|
(4,928) |
|
|
— |
Amortization of acquisition-related inventory step-up(3) |
|
|
— |
|
|
— |
|
|
— |
|
|
5,054 |
Credit agreement amendment fee(4) |
|
|
— |
|
|
— |
|
|
1,600 |
|
|
— |
Accrual for multi-employer pension plan withdrawal liability(5) |
|
|
— |
|
|
14,056 |
|
|
— |
|
|
14,056 |
Impairment of assets held for sale(6) |
|
|
103,625 |
|
|
— |
|
|
103,625 |
|
|
— |
Tax effects of non-GAAP adjustments(7) |
|
|
(26,560) |
|
|
(5,009) |
|
|
(26,919) |
|
|
(8,165) |
Adjusted net income |
|
$ |
22,267 |
|
$ |
36,182 |
|
$ |
47,282 |
|
$ |
97,338 |
Adjusted diluted earnings per share |
|
$ |
0.31 |
|
$ |
0.55 |
|
$ |
0.67 |
|
$ |
1.49 |
__________________________ | ||
(1) |
|
Acquisition/divestiture-related and non-recurring expenses for the third quarter and first three quarters of 2022 primarily includes acquisition and integration expenses for the Yuma and Crisco acquisitions. Acquisition/divestiture-related and non-recurring expenses for the third quarter and first three quarters of 2021 primarily includes acquisition and integration expenses for the Crisco acquisition and certain cost savings initiatives. |
|
|
|
(2) |
|
During the first quarter of 2022, the Company completed the closure and sale of its |
|
|
|
(3) |
|
For the first three quarters of 2021, amortization of acquisition-related inventory step-up of |
|
|
|
(4) |
|
During the second quarter of 2022, the Company paid a fee of |
|
|
|
(5) |
|
During the third quarter of 2021, the Company reached an agreement to sell its |
|
|
|
(6) |
|
In connection with the Company’s previously announced transition to a business unit structure, the Company has decided to divest its Back to Nature business, which is no longer core to the Company’s overall business or long-term strategy. The Company is actively seeking to sell the Back to Nature business. As a result, the Company reclassified |
|
|
|
(7) |
|
Represents the tax effects of the non-GAAP adjustments listed above assuming a tax rate of |
Items Affecting Comparability
Reconciliation of Base Business (In thousands) (Unaudited) |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third Quarter Ended |
|
First Three Quarters Ended |
||||||||
|
|
|
|
|
|
|
|
|
||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Net sales |
|
$ |
528,396 |
|
$ |
514,965 |
|
$ |
1,539,768 |
|
$ |
1,484,474 |
Net sales from acquisitions(2) |
|
|
(876) |
|
|
— |
|
|
(1,518) |
|
|
— |
Net sales from discontinued brands(3) |
|
|
20 |
|
|
(464) |
|
|
(267) |
|
|
(2,282) |
Base business net sales |
|
$ |
527,540 |
|
$ |
514,501 |
|
$ |
1,537,983 |
|
$ |
1,482,192 |
__________________________ | ||
(1) |
|
Base business net sales is a non-GAAP financial measure used by management to measure operating performance. The Company defines base business net sales as the Company’s net sales excluding (1) the net sales of acquisitions until the net sales from such acquisitions are included in both comparable periods and (2) net sales of discontinued or divested brands. The portion of current period net sales attributable to recent acquisitions for which there is no corresponding period in the comparable period of the prior year is excluded. For each acquisition, the excluded period starts at the beginning of the most recent fiscal period being compared and ends on the first anniversary of the acquisition date. For discontinued or divested brands, the entire amount of net sales is excluded from each fiscal period being compared. The Company has included this financial measure because management believes it provides useful and comparable trend information regarding the results of the Company’s business without the effect of the timing of acquisitions and the effect of discontinued or divested brands. |
(2) |
|
Reflects net sales from the Yuma acquisition, for which there is no comparable period of net sales during the third quarter and first three quarters of 2021, respectively. The Yuma acquisition was completed on |
(3) |
|
Reflects net sales of the SnackWell’s and Farmwise brands, which have been discontinued. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221109005978/en/
Investor Relations:
866.211.8151
Media Relations:
203.682.8214
Source:
FAQ
What were BGS's net sales for the third quarter of 2022?
What is BGS's adjusted EBITDA for Q3 2022?
How much did BGS lose in net income for the third quarter of 2022?
What is the full-year sales guidance for BGS?